FDA issued a Warning Letter to Zhejiang Huahai Pharmaceutical on 11/29/2018 for a later inspection.
483 Zhejiang Huahai Pharmaceutical May 2017

483 Zhejiang Huahai Pharmaceutical May 2017

Massoud Motamed FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Huahai Pharmaceutical - Linhai, China facility and issued inspectional observations (via FDA 483) on 19 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 19 May 2017
  • Location: Linhai, China
  • FEI: 3003885745
Add To Cart